Mostrando ítems 1-1 de 1
Identification of cleavage regulatory mechanisms and phenotypic consequences to targeting of the ADAM 17/ EGFR axis in triple negative breast cancer (TNBC) in-vitro
(Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica, 2015)